BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31232887)

  • 1. Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review.
    Lekbua A; Ouahed J; O'Connell AE; Kahn SA; Goldsmith JD; Imamura T; Duncan CN; Kelsen JR; Worthey E; Snapper SB; Softic S
    J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):e13-e18. PubMed ID: 31232887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.
    Ono S; Okano T; Hoshino A; Yanagimachi M; Hamamoto K; Nakazawa Y; Imamura T; Onuma M; Niizuma H; Sasahara Y; Tsujimoto H; Wada T; Kunisaki R; Takagi M; Imai K; Morio T; Kanegane H
    J Clin Immunol; 2017 Jan; 37(1):85-91. PubMed ID: 27815752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic colitis in a boy with a novel XIAP mutation: a case report.
    Tang J; Zhou X; Wang L; Hu G; Zheng B; Wang C; Lu Y; Jin Y; Guo H; Liu Z
    BMC Pediatr; 2020 Apr; 20(1):171. PubMed ID: 32305064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.
    Speckmann C; Lehmberg K; Albert MH; Damgaard RB; Fritsch M; Gyrd-Hansen M; Rensing-Ehl A; Vraetz T; Grimbacher B; Salzer U; Fuchs I; Ufheil H; Belohradsky BH; Hassan A; Cale CM; Elawad M; Strahm B; Schibli S; Lauten M; Kohl M; Meerpohl JJ; Rodeck B; Kolb R; Eberl W; Soerensen J; von Bernuth H; Lorenz M; Schwarz K; Zur Stadt U; Ehl S
    Clin Immunol; 2013 Oct; 149(1):133-41. PubMed ID: 23973892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency.
    Girardelli M; Arrigo S; Barabino A; Loganes C; Morreale G; Crovella S; Tommasini A; Bianco AM
    BMC Pediatr; 2015 Dec; 15():208. PubMed ID: 26671016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [X-linked inhibitor of apoptosis deficiency manifested as Crohn's disease: a case report and literature review].
    Xu LJ; Luo YY; Yu JD; Lou JG; Fang YH; Chen J
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):43-47. PubMed ID: 29342997
    [No Abstract]   [Full Text] [Related]  

  • 7. How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.
    Nielsen OH; LaCasse EC
    Genet Med; 2017 Feb; 19(2):133-143. PubMed ID: 27416006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency.
    Yang L; Booth C; Speckmann C; Seidel MG; Worth AJJ; Kindle G; Lankester AC; Grimbacher B; ; Gennery AR; Seppanen MRJ; Morris EC; Burns SO
    J Allergy Clin Immunol; 2022 Aug; 150(2):456-466. PubMed ID: 34920033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency.
    Ono S; Takeshita K; Kiridoshi Y; Kato M; Kamiya T; Hoshino A; Yanagimachi M; Arai K; Takeuchi I; Toita N; Imamura T; Sasahara Y; Sugita J; Hamamoto K; Takeuchi M; Saito S; Onuma M; Tsujimoto H; Yasui M; Taga T; Arakawa Y; Mitani Y; Yamamoto N; Imai K; Suda W; Hattori M; Ohara O; Morio T; Honda K; Kanegane H
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3767-3780. PubMed ID: 34246792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absent X-linked inhibitor of apoptosis protein expression in T cell blasts and causal mutations including non-coding deletion.
    Abdrabou SSMA; Toita N; Ichihara S; Tozawa Y; Takahashi M; Fujiwara SI; Ashida T; Ohara O; Ariga T; Manabe A; Konno M; Yamada M
    Pediatr Int; 2022 Jan; 64(1):e14892. PubMed ID: 34145698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic characteristics of XIAP deficiency in Japan.
    Yang X; Kanegane H; Nishida N; Imamura T; Hamamoto K; Miyashita R; Imai K; Nonoyama S; Sanayama K; Yamaide A; Kato F; Nagai K; Ishii E; van Zelm MC; Latour S; Zhao XD; Miyawaki T
    J Clin Immunol; 2012 Jun; 32(3):411-20. PubMed ID: 22228567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful allogeneic hematopoietic stem cell transplantation in a boy with X-linked inhibitor of apoptosis deficiency presenting with hemophagocytic lymphohistiocytosis: A case report.
    Jiang MY; Guo X; Sun SW; Li Q; Zhu YP
    Exp Ther Med; 2016 Sep; 12(3):1341-1344. PubMed ID: 27602064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report.
    Kelsen JR; Dawany N; Martinez A; Grochowski CM; Maurer K; Rappaport E; Piccoli DA; Baldassano RN; Mamula P; Sullivan KE; Devoto M
    BMC Gastroenterol; 2015 Nov; 15():160. PubMed ID: 26581487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.
    Chirieleison SM; Marsh RA; Kumar P; Rathkey JK; Dubyak GR; Abbott DW
    J Biol Chem; 2017 Jun; 292(23):9666-9679. PubMed ID: 28404814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.
    Miller TL; Lee D; Giefer M; Wahbeh G; Suskind DL
    Dig Dis Sci; 2017 Aug; 62(8):2196-2200. PubMed ID: 28551707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
    Marsh RA; Madden L; Kitchen BJ; Mody R; McClimon B; Jordan MB; Bleesing JJ; Zhang K; Filipovich AH
    Blood; 2010 Aug; 116(7):1079-82. PubMed ID: 20489057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal outcome of bone marrow transplantation for monogenic inflammatory bowel disease.
    Morita M; Takeuchi I; Kato M; Migita O; Jimbo K; Shimizu H; Yoshimura S; Tomizawa D; Shimizu T; Hata K; Ishiguro A; Arai K
    Pediatr Int; 2022 Jan; 64(1):e14750. PubMed ID: 33884705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.
    Aguilar C; Lenoir C; Lambert N; Bègue B; Brousse N; Canioni D; Berrebi D; Roy M; Gérart S; Chapel H; Schwerd T; Siproudhis L; Schäppi M; Al-Ahmari A; Mori M; Yamaide A; Galicier L; Neven B; Routes J; Uhlig HH; Koletzko S; Patel S; Kanegane H; Picard C; Fischer A; Bensussan NC; Ruemmele F; Hugot JP; Latour S
    J Allergy Clin Immunol; 2014 Nov; 134(5):1131-41.e9. PubMed ID: 24942515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.
    Dziadzio M; Ammann S; Canning C; Boyle F; Hassan A; Cale C; Elawad M; Fiil BK; Gyrd-Hansen M; Salzer U; Speckmann C; Grimbacher B
    J Clin Immunol; 2015 Jul; 35(5):439-44. PubMed ID: 25943627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
    Topal J; Panchal N; Barroeta A; Roppelt A; Mudde A; Gaspar HB; Thrasher AJ; Houghton BC; Booth C
    J Clin Immunol; 2023 Feb; 43(2):440-451. PubMed ID: 36329240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.